Pharming Group NV

Nov 06, 2025

Pharming Group NV Q3 2025 Earnings Report

Estimated Revenue:$84.8M

+10.2% YoY

Estimated EPS:$0.02

+100.0% YoY

Unlock previous datapoints

Unlock previous datapoints

Loading...

Analyze how earnings announcements historically affect stock price performance

Loading earnings performance data...

Loading earnings reaction data...

Full financial data and analysis

Market Cap

$1.42B

P/E Ratio

-6.07

Sector

N/A

Industry

N/A

52-Week High

$1.77

52-Week Low

$0.688